# Special Drug Use-Results Survey of Prograf Capsule in Rheumatoid Arthritis Patients

> **NCT01870908** · — · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 664 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** tacrolimus
- **DRUG:** biological agents

## Key facts

- **NCT ID:** NCT01870908
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 664 (ACTUAL)
- **Last updated:** 2015-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01870908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01870908, "Special Drug Use-Results Survey of Prograf Capsule in Rheumatoid Arthritis Patients". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT01870908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*